September 15, 2010 – Results from the PARTNER Trial Cohort B will be presented at 11 a.m. on Thursday, Sept. 23, at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 scientific symposium in Washington, D.C.
A new class of antiplatelet therapy drug pending U.S. Food and Drug Administration (FDA) clearance may offer greater benefits over clopidogrel (Plavix) the current standard of therapy. The new drug also offers the ability to have its effects reversed quickly.

Over the past five years, two major changes have occurred in cardiovascular information systems (CVIS) and cardiovascular picture archiving and communications systems (PACS). There is a migration from disparate reporting and imaging systems toward a single, unified system. The second trend is easier access to patient information using Web-based and cloud technology.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

In this era of financial cost-cutting, questions are raised over the true need for 256- or 320-slice computed tomography (CT) systems for cardiac imaging. There are many radiologists and cardiologists who argue a 64-slice CT system is good enough to make a cardiac diagnosis without spending twice as much for the higher-slice systems.

Advancements in newer 64-slice computed tomography (CT) systems and the introduction of 256- and 320-slice systems are helping to significantly reduce exposure to ionizing radiation.
September 15, 2010 — As the result of a new partnership, the Image-Arena advanced visualization software will be integrated into the Impax cardiovascular picture archiving and communication system (PACS). Agfa HealthCare has signed an agreement with TomTec to add its Image-Arena solution into Agfa's Impax Cardiovascular.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
September 15, 2010 – The U.S. Food and Drug Administration (FDA) granted 510(k) market approval for the Medivance noninvasive Arctic Sun 5000 therapeutic temperature management device. The new patient cooling device offers fast initiation of treatment, simple programming capabilities and easy access to treatment.
September 15, 2010 – A study evaluating the level of platelet aggregation achieved after switching from clopidogrel (Plavix) 75 mg once-daily maintenance dosing plus aspirin to prasugrel (Effient) 10 mg once-daily maintenance dosing (MD) in patients with acute coronary syndrome (ACS) was published today in the Journal of the American College of Cardiology.
September 15, 2010 – The U.S. Food and Drug Administration (FDA) has extended the time to complete its review of the new drug application (NDA) for ticagrelor (Brilinta), which is the first reversible oral antiplatelet drug.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
September 15, 2010 – A high-definition intravascular ultrasound (IVUS) system will be demonstrated during the Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium Sept. 21-25 in Washington, D.C.

September 14, 2010 – Transcatheter valves, drug-eluting balloons and the latest stent comparison trial data are among the top three trends at Transcatheter Cardiovascular Therapeutics (TCT) 2010 scientific sessions Sept. 21-25 in Washington, D.C.
September 14, 2010 –To support proactive patient care for those at risk for worsening heart failure, Medtronic this week introduced the CareLink Network for Heart Failure. The remote monitoring system is an extension of the current CareLink system for implantable cardiac device monitoring system. The new system will be available this fall.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
September 14, 2010 – The latest clinical trial data for the Promus Element and Taxus Element coronary stents will be released during the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, Sept. 21–25, in Washington, D.C.
September 10, 2010 – Cath Labs are being encouraged this week by the U.S. Food and Drug Administration (FDA) to inspect their inventories for AngioSculpt EX Percutaneous Transluminal Coronary Angioplasty (PTCA) Scoring Balloon Catheters. Devices manufactured between Jan. 30 and Dec. 4, 2009 are part of a class 1 product recall due to safety concerns.
September 10, 2010 – The U.S. Food and Drug Administration (FDA) is requiring that gadolinium-based contrast agents (GBCAs) carry new warnings on their labels about the risk of a rare and potentially fatal condition known as nephrogenic systemic fibrosis (NSF). The condition may occur if the drug is administered to certain patients with kidney disease.